• Marietta Iacucci, Rosanna Cannatelli, Nunzia Labarile, Ren Mao, Remo Panaccione, Silvio Danese, Gursimran S Kochhar, Subrata Ghosh, and Bo Shen.
• Institute of Translational of Medicine, Institute of immunology and immunotherapy and NIHR Biomedical Research Centre, University of Birmingham and University Hospitals Birmingham NHS Foundation Trust, UK; Department of Gastroenterology and Hepatology, University of Calgary, Calgary, AB, Canada.
• Lancet Gastroenterol Hepatol. 2020 Jun 1; 5 (6): 598-606.

AbstractThe coronavirus disease 2019 (COVID-19) pandemic is changing the management of many chronic diseases, including that of patients with inflammatory bowel diseases (IBD). In particular, the performance of routine endoscopy is temporarily suspended, and only emergency endoscopy is allowed in many countries where severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread. We highlight different scenarios in which endoscopy should still be performed urgently in patients with IBD, as well as recommendations regarding the use of personal protective equipment. We suggest a pathway for performing safe endoscopy and discuss the potential risks of postponing endoscopy in IBD. Finally, we propose a post-pandemic plan for access to endoscopy.Copyright © 2020 Elsevier Ltd. All rights reserved.

16 keywords...

hide…